Free Trial

More results...

Filter by Content types
Regulatory databases
Regulatory reports
Market reports
News analysis
Filter by Geography
Africa
Asia
Australasia
Europe
United Kingdom
North America
United States
South America

Alerts LATEST ALERTS

  • Brazil Up to 0.3% THC in plants authorised for medical, pharmaceutical, industrial use ...
  • Australia Parliamentary committee makes suggestions for cannabis law in NSW ...
  • Australia Greens announce Parliament will vote on cannabis legalisation this month ...
  • Texas - United States Bills introduced in Senate and House on medical cannabis expansion ...
  • Texas - United States House bill introduced to regulate hemp production and require research permit ...
  • Texas - United States House bills introduced on legalising recreational cannabis ...
  • Lithuania - Ukraine Cannabis conference focuses on fibre hemp, addressing challenges, restrictions ...
  • Czech Republic Criminal law reform approved, will relax some cannabis-related laws ...
  • New Zealand First sublingual THC/CBD spray meets Medicinal Cannabis Agency quality standard ...
  • Poland Motion for cannabis decriminalisation presented to prime minister ...
  • Belgium Health Belgium updates notified herbal products for smoking list ...
  • Portugal Infarmed withdraws several CBD products from market ...
View all
Regulatory reports

Regulatory report: Central America, March 2022

Written by Fernanda Tucunduva | 4th March 2022

Covers: Belize, Costa Rica, El Salvador, Guatemala, Honduras, Nicaragua, Panama. Overall, the region is restrictive on hemp and cannabis, with exceptions being Belize, Costa Rica and Panama ...

Medical and recreational cannabis – a global overview

Written by CannIntelligence | 4th March 2022

CBD-Intel has compiled and classified regulatory data on medical and recreational cannabis in over 50 jurisdictions around the world. This report is accompanied by a detailed database outlining the regulatory situation in selected countries ...

Regulatory report: Hungary, January 2022

Written by Sergi Riudalbàs Clemente | 10th January 2022

This report offers a comprehensive overview of the current regulations in place in Hungary for CBD and related products, including laws around medical and recreational cannabis ...

Regulatory report: Germany, December 2021

Written by Fernanda Tucunduva | 14th December 2021

Changes are on the horizon for Germany's recreational cannabis regime. This report covers Germany's regulatory framework for hemp, CBD and cannabis ...

Regulatory report: Slovenia, December 2021

Written by Sergi Riudalbàs Clemente | 2nd December 2021

Slovenia's stance on CBD in the light of the Kanavape case isn't clear; recreational cannabis rules not likely change; medicinal cannabis rules might change ...

Regulatory report: Chile, October 2021

Written by Laura Garay Gómez | 5th October 2021

Chile has maintained a rather restrictive approach towards hemp and CBD. It has only recently allowed medicinal use of cannabis-based products, but there are still many legal grey areas as a consequence of the lack...

Regulatory report: cannabis delivery in the US

Written by Anthony Traurig | 29th September 2021

This regulatory report examines which of the 36 US states that have legalised medical and/or recreational cannabis sales allow for home deliveries of cannabis products ...

Regulatory report: Norway, July 2021

Written by Lorenzo Guaragna | 13th July 2021

Cannabis and hemp fall under the same regulatory framework in Norway. This report addresses the current legal regime for CBD, hemp and cannabis ...

Regulatory report: China, July 2021

Written by Rui Feng | 12th July 2021

This report offers a regulatory overview of hemp and CBD in China, covering mainland China, as well as provincial regulations in Yunnan and Heilongjiang ...

Regulatory report: Finland, July 2021

Written by Dmytro Korchahin | 12th July 2021

This report provides a comprehensive overview of the current regulatory framework for hemp, CBD and cannabis in Finland, covering all areas from cultivation to finished products and import/export restrictions ...

Regulatory report: CBD as a dietary supplement in the US and EU

Written by CannIntelligence | 28th June 2021

As CBD grows in popularity, its regulatory status remains poorly defined. In this report CBD-Intel reviews the regulatory framework of dietary supplements and where CBD fits, or would fit, within that framework ...

Regulatory report: Austria, June 2021

Written by Lorenzo Guaragna | 10th June 2021

This regulatory report looks at the current situation for CBD in Austria, focusing on cultivation, processing, import and export, extracts and finished products ...

Regulatory report: Spain, May 2021

Written by Laura Garay Gómez | 25th May 2021

Significant changes are not expected for Spanish CBD and cannabis regulation in the short term as the main political parties remain conservative. This report provides an overview of the current status of CBD, hemp and...

Regulatory report: Bulgaria, May 2021

Written by Nicolas Makrides | 24th May 2021

This report offers an overview of the current regulatory regime in Bulgaria for CBD, hemp and cannabis, covering all areas from cultivation and processing to finished products, and medical and recreational cannabis ...

Regulatory report: delta-8 THC in the US 

Written by Anthony Traurig | 19th May 2021

Delta-8 THC has emerged as the hottest new cannabinoid in the US market. This report examines federal law on delta-8, notes trends that are happening at state level, and discusses what the future may hold...

Regulatory report: UK, May 2021

Written by Marija Obradovic | 10th May 2021

This report offers an in-depth look at the current regulatory framework for hemp, CBD and cannabis in the UK, including its medical and recreational cannabis regime ...

Regulatory report: Slovakia, April 2021

Written by Dmytro Korchahin | 28th April 2021

CBD will become legal for the first time in Slovakia on 1st May 2021. This report offers a detailed overview of the regulatory framework in the country for hemp, CBD and medical and recreational cannabis...

Regulatory report: Denmark, April 2021

Written by Lorenzo Guaragna | 13th April 2021

Cultivation of hemp with less than 0.2% THC is legal in Denmark. This report provides an overview of the country's regulatory framework for CBD, hemp and cannabis ...

Regulatory report: Sweden, April 2021

Written by Dmytro Korchahin | 8th April 2021

This report offers an overview of the current regulatory framework in place for hemp, CBD and cannabis in Sweden ...

Regulatory report: France, April 2021

Written by CannIntelligence | 8th April 2021

The future regulation, and interpretation of existing rules, of cannabis in all its forms is a recurring subject in France. This report provides an overview of the current regulatory framework ...

Regulatory report: South Africa, April 2021

Written by Marija Obradovic | 1st April 2021

This report covers the current regulatory regime for hemp, CBD and cannabis in South Africa, including the regimes for medical and recreational cannabis ...

Regulatory report: Switzerland, March 2021

Written by Laura Garay Gómez | 29th March 2021

Switzerland is currently experiencing important changes in its cannabis regulation. This report details the current regulatory framework for hemp, CBD and cannabis, and provides information on forthcoming changes ...

Regulatory report: Poland, March 2021

Written by Laura Garay Gómez | 19th March 2021

This report offers an overview of the current regulations in place for CBD and cannabis in Poland, including all aspects from cultivation and processing, to finished products, medical and recreational cannabis ...

Regulatory report: Netherlands, February 2021

Written by Dmytro Korchahin | 15th February 2021

The broad legal framework for hemp, CBD and medical cannabis in the Netherlands will remain unchanged for now due to upcoming parliamentary elections. This report covers the current rules for cannabis and CBD ...

Regulatory report: Canada, February 2021

Written by Anthony Traurig | 8th February 2021

Canada permits the cultivation, production, distribution, and sale of hemp, cannabis, and products derived from them, but only by those licensed to do so by the government. This report offers a detailed overview of the...

CBD product labelling – a US state-by-state analysis

Written by Anthony Traurig | 14th January 2021

This report details the labelling requirements for CBD products of all US states that have enacted regulations and shows how manufacturers can create a versatile label to satisfy as many states' regulations as possible ...

Regulatory report: Philippines, January 2021

Written by CannIntelligence | 13th January 2021

A debate on regulating cannabis for medicinal use is on the table in the Philippines, and several bills are currently being discussed. This report provides an overview of the current regulatory regime for CBD and...

Regulatory report: North Macedonia, January 2021

Written by CannIntelligence | 11th January 2021

Unlike psychoactive cannabis, cultivation and processing of industrial hemp is not allowed in North Macedonia – however this may change. This report offers an overview of the current and likely future legal framework ...

Regulatory report: Cyprus, December 2020

Written by CannIntelligence | 15th December 2020

CBD is considered a medicine in Cyprus and any CBD-infused product would be classified as a medicinal product. The report covers the current regulatory regime in place ...

Regulatory report: Ecuador, December 2020

Written by CannIntelligence | 10th December 2020

This report provides a detailed overview of the current regulatory regime in place for hemp and CBD in Ecuador, as well as information on medical and recreational cannabis ...

Sign up to our newsletter

Stay up-to-date with key market trends and regulatory news and receive complimentary data on a regular basis.

"*" indicates required fields

Name*
*
This field is for validation purposes and should be left unchanged.